Monitoring recommendations Beyond the standard tirzepatide monitoring parameters, autoimmune patients should track additional markers
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 "Carnitine"
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers Hims & Hers Health, Inc., a leading health and wellness platform, announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving customers an affordable way to consistently access safe, high-quality weight loss treatment
Notably, several of the GLP-1 RAs examined in these studies (e.g., exenatide, lixisenatide) are gradually being retired from clinical use, while the therapeutic landscape is shifting toward newer GLP-1 RAs (e.g., semaglutide) and dual-or triple-agonist compounds (e.g., tirzepatide, retatrutide)
In patients with type 2 diabetes and established cardiovascular disease, semaglutide has been shown to reduce the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or cardiovascular death
All medications are prescribed based on an individual clinical evaluation by a licensed medical provider
